Sarepta Under Pressure Amid Concerning Exondys 51 Survey Results
February 01, 2017 at 11:55 AM EST
Shares of Sarepta Therapeutics Inc (NASDAQ: SPRT) were under heavy selling pressure following a concerning report released by ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.